Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.
about
Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus modelMurine CMV-induced hearing loss is associated with inner ear inflammation and loss of spiral ganglia neuronsAberrant fetal macrophage/microglial reactions to cytomegalovirus infection.Ventricular shunt infections: immunopathogenesis and clinical management.Cytomegalovirus Infection of the Rat Developing Brain In Utero Prominently Targets Immune Cells and Promotes Early Microglial ActivationSOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection.Lithium protects against glucocorticoid induced neural progenitor cell apoptosis in the developing cerebellum.Models of vertical cytomegalovirus (CMV) transmission and pathogenesis.Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.Tumor Necrosis Factor Alpha-Induced Recruitment of Inflammatory Mononuclear Cells Leads to Inflammation and Altered Brain Development in Murine Cytomegalovirus-Infected Newborn Mice.Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma.Immune responses to congenital cytomegalovirus infection.In Utero Administration of Drugs Targeting Microglia Improves the Neurodevelopmental Outcome Following Cytomegalovirus Infection of the Rat Fetal Brain.In Utero Administration of Drugs Targeting Microglia Improves the Neurodevelopmental Outcome Following Cytomegalovirus Infection of the Rat Fetal Brain.
P2860
Q27026924-6D65E2FA-15A9-4C6D-8A34-92B0ECCE71A3Q27320589-0FD41CD9-598C-4FE8-A70C-65CF7D3848A6Q34286411-DB261B95-655F-4914-99DC-2496DBC7C82FQ34619785-714E806D-192A-4516-A90F-E6CD7906AF3CQ36089808-27569616-ACB4-44EB-AE20-57F6A1AC0987Q36548775-961A292D-73C6-41A2-B5DA-025CA07F779BQ37197940-0BD12FB9-47F7-4FBA-A435-FC07D601EFC9Q37572261-D670BE38-698E-407E-B43C-EC9EFEBCD14BQ38257810-0B8D466D-62E6-4A70-951C-67E2256CA837Q38718373-F7E4CEAB-A992-4296-8375-5520A796BC86Q40358106-31283266-2D2A-4FBD-9218-36C2AD23EF0DQ47102677-863CE46E-96DC-42DE-BE99-B52CF4B0890CQ47559622-B65C1AB1-4DEE-4BA1-B1AB-F4BFC9B76468Q52645969-A1C61ED1-9837-4E40-AFE4-12BDCBE51E24Q55001631-59D6692A-9296-4287-A25B-CAACFA06806F
P2860
Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Glucocorticoid treatment of MC ...... its in cerebellar development.
@ast
Glucocorticoid treatment of MC ...... its in cerebellar development.
@en
Glucocorticoid treatment of MC ...... its in cerebellar development.
@nl
type
label
Glucocorticoid treatment of MC ...... its in cerebellar development.
@ast
Glucocorticoid treatment of MC ...... its in cerebellar development.
@en
Glucocorticoid treatment of MC ...... its in cerebellar development.
@nl
prefLabel
Glucocorticoid treatment of MC ...... its in cerebellar development.
@ast
Glucocorticoid treatment of MC ...... its in cerebellar development.
@en
Glucocorticoid treatment of MC ...... its in cerebellar development.
@nl
P2093
P2860
P1433
P1476
Glucocorticoid treatment of MC ...... cits in cerebellar development
@en
P2093
Ester P Pugel
Glenn R Bantug
Kate Kosmac
William J Britt
P2860
P304
P356
10.1371/JOURNAL.PPAT.1003200
P577
2013-03-07T00:00:00Z